The U.S. life settlement market transacts approximately $4.5–$5 billion in face value annually against an addressable gross market potential of $224 billion — a penetration rate of roughly 2.25%. Conning's 2025 strategic study, titled "A Pause for Now," documents a temporary slowdown in 2024 but maintains a forecast of $4.6 billion average annual transaction volume across 2025–2034. The supply-demand imbalance reflects structural inefficiency: millions of life insurance policies lapse or surrender annually for cash values that are 4–7× lower than secondary market value, while institutional capital seeking allocation continues to grow. Invest in life settlements through HYV in a market where deep institutional supply meets disciplined direct-ownership demand.
Most accredited investors entering the life settlement market hear headline statistics but rarely see the underlying decade-long data series, the supply gap math, or the structural reasons the asset class persists despite its size. The Conning 20th annual strategic study, released November 2025 under the title "A Pause for Now," is the most authoritative publicly-available framework for understanding U.S. market mechanics. After two decades tracking these dynamics across multiple market cycles, the analysis below integrates Conning's framework with operational observations from inside the direct-ownership channel — supply timing, geographic distribution, and the demographic engine that drives forward growth expectations.
The 2026 market size and recent volume series
The U.S. life settlement market measured by annual face value transacted has moved through a relatively stable band over the past decade, recovering from post-Global Financial Crisis lows and stabilizing in the $4–5 billion range. Conning's 20th annual study, the most comprehensive industry data source, projects average annual volume of approximately $4.6 billion across the 2025–2034 forecast period, with the title "A Pause for Now" reflecting a measurable 2024 slowdown but consistent long-term growth expectations.
The decade-long volume series below shows the trajectory clearly. Volume bottomed at $1.3 billion in 2011, has trended upward through the 2010s into the $4–5 billion range, peaked at $4.8 billion in 2023, and paused in 2024 — the source of the Conning study's framing. The European Life Settlement Association (ELSA) and the Life Insurance Settlement Association (LISA) publish complementary annual data confirming these magnitudes.
Ten-year series 2015–2024
Three observations from the decade series. First, the market has tripled in face value transacted since the 2011 trough ($1.3B to $4.3–4.8B range), reflecting institutional capital migration into the asset class and demographic supply growth. Second, the 2024 pause was modest in magnitude — Conning frames it as a temporary slowdown rather than a structural turn, attributing it primarily to economic uncertainty, equity market dynamics, and consumer hesitation rather than to fundamental shifts in the demographic supply or institutional demand picture.
Third, even the peak years remain dramatically below historical highs. Pre-Global Financial Crisis, the market hit $12.2 billion in 2007 — but that volume was inflated by premium finance programs that created artificial supply rather than reflecting genuine demand for life settlement liquidity. The modern market, while smaller in absolute face value, is structurally healthier because supply originates from genuine policyholder need rather than financing-driven artificial origination.
Conning's projected average annual transaction volume across 2025–2034 in the 20th annual study, "A Pause for Now." The forecast reflects favorable demographic drivers and continued institutional capital interest, balanced against shorter-term economic uncertainty. See the Conning 2025 strategic study release for the authoritative source.
The supply gap — $224B potential vs $4.6B transacted
The single most striking number in the Conning framework is the gap between the addressable market and the transacted market. Conning estimates average annual gross market potential at $224 billion — meaning the face value of policies held by U.S. seniors aged 65+ that meet the structural eligibility criteria for a life settlement transaction (sufficient face value, in-force, post-contestability period, suitable policy type). Against that $224 billion potential, the market transacts approximately $4.6 billion annually — a penetration rate of roughly 2.25%.
The supply gap exists because most eligible policies never reach the secondary market. They either lapse (policyholder stops paying premiums), surrender (policyholder accepts the carrier's cash surrender value), or simply remain in force without optimization. The structural inefficiency is that lapse and surrender produce values that are 4–7× lower than secondary market valuations would deliver — meaning policyholders consistently leave substantial value on the table because they don't know the secondary market exists or how to access it.
Eligible policy supply
U.S. seniors 65+ with policies meeting structural criteria (face value, in-force status, contestability, suitable type)
Policyholders aware of option
Subset of eligible holders who know life settlements exist as an alternative to lapse or surrender (industry estimates ~25–30%)
Policyholders seeking offers
Subset who actively engage brokers or providers for policy appraisal (industry estimates ~15–20%)
Annual face value actually sold
Policies that complete the secondary market transaction — Conning 10-year forecast average
The penetration funnel reveals where the structural opportunity lies. The bottleneck is not capital — institutional and accredited investor demand has consistently exceeded annual transaction volume. The bottleneck is awareness and originator capacity. Most eligible policyholders are not aware life settlements exist as an option. Of those who become aware, only a fraction actively pursue offers. Of those who do, transaction friction (regulatory waiting periods, underwriting timelines, broker capacity) constrains how many close per year.
For accredited investors and family offices, this supply structure means two things. First, deep demand-supply imbalance favors capital deployment — institutional buyers have consistently found policies meeting their diligence standards. Second, the institutional discipline of working with established platforms (which have originator relationships and underwriting infrastructure) matters more than chasing direct policyholder relationships, where access and pacing constraints make individual sourcing impractical at scale. The structural mechanics are covered in our online life settlement marketplace article.
Browse vetted life settlement opportunities
HYV opportunities are sourced from across the U.S. secondary market with full institutional diligence applied — LE underwriting, carrier rating, regulatory compliance — and presented to accredited investors at scale.
Browse the platformGrowth drivers and the Conning 10-year forecast
Conning's analytical framework identifies four primary growth drivers behind the $4.6B average annual forecast for 2025–2034. None alone guarantees market expansion; their aggregate strength supports the long-term trajectory expectation.
Demographic momentum is the structural foundation. Approximately 10,000 Americans reach age 65 each day as the baby boomer cohort moves through the eligible age band for life settlements. The 65+ population in the U.S. is projected to grow from roughly 58 million in 2026 to over 80 million by 2040 according to U.S. Census projections. Each additional senior with an eligible policy expands the addressable supply, regardless of penetration rate dynamics. This is the slowest-moving but most reliable driver of secular market expansion.
Interest rate environment supports investor demand. Life settlement returns operate independently of interest rate cycles — the IRR is driven by mortality timing relative to LE estimates, not by bond yields or equity market returns. When traditional fixed income offers limited real yield, accredited investors and family offices look to alternatives with comparable risk profiles but uncorrelated returns. The 2022–2024 rate environment renewed institutional interest in the asset class as an income-replacement alternative to traditional bond allocations. This dynamic is covered in our overview article on life settlement investing.
Awareness expansion is incremental but persistent. Industry education efforts by LISA, state insurance regulators, and individual platforms have gradually increased policyholder awareness of the secondary market option. The Conning study notes the development of a broader direct-to-consumer life settlement market widening access. Even modest awareness gains compound — moving from 25% to 35% policyholder awareness over a decade would substantially expand annual transaction volume even without changes in conversion rates downstream.
Regulatory stability supports market confidence. The state regulatory framework (43 states plus DC with comprehensive statutes) has stabilized over the past 15 years. Anti-STOLI provisions have screened out the lowest-quality supply that destabilized the market in the late 2000s. The institutional underwriting infrastructure (21st Services, ISC, Fasano, Predictive Resources) operates under ASOP No. 48 standardization. This regulatory and operational maturity reduces the perceived legal and reputational risk that previously discouraged some institutional allocators from entering the asset class.
Against these drivers, Conning identifies countervailing factors that explain the 2024 pause: continued economic uncertainty affecting policyholder decision-making, rising interest rates initially pulling some institutional capital back into fixed income, and equity market volatility absorbing alternative allocation budgets. The study's "Pause for Now" framing suggests these are cyclical headwinds against structural tailwinds — implying the forecast 10-year average ($4.6B annual) reflects mean reversion to the secular growth trajectory.
What market structure means for accredited investors
Pulling the threads together, the 2026 market structure carries specific implications for accredited investors deploying capital in the asset class. The framework below summarizes the key takeaways for portfolio-level decision-making.
- Annual supply substantially exceeds typical investor demand. A $4.6 billion annual transaction volume across thousands of policies means individual accredited investors have access to genuine supply across multiple LE bands, carriers, and impairment categories — supporting the diversification framework covered in our step-by-step investment guide.
- The supply-demand imbalance is structural, not cyclical. The 2.25% penetration rate has remained stable across multiple market cycles. Even meaningful demand growth from institutional capital does not fully absorb addressable supply — which protects pricing discipline for disciplined buyers.
- Geographic distribution favors institutional platforms. Policies originate across all 50 states with concentration in regulated states (43 of 50). Individual accredited investors accessing the market through institutional platforms gain national supply access; direct relationships are operationally constrained by geographic reach.
- The 2024 pause is informative but not structural. Conning's analysis frames the slowdown as cyclical against persistent long-term drivers. Accredited investors should view current market conditions as a normal operating environment rather than an inflection requiring strategy revision.
For investors evaluating whether to enter the asset class or expand existing allocations, the structural market context supports patient, disciplined capital deployment over time. The accredited investors who invest in life settlement policies through HYV typically build positions over 12–24 months across the four-axis diversification framework — taking advantage of the deep supply pool rather than rushing to deploy capital in any single quarter.
Invest in life settlements in a $4.6B annual market
HYV opportunities are sourced from the U.S. secondary market with full institutional diligence — LE underwriting, carrier rating, regulatory compliance — and sized appropriately for accredited investor portfolios at every capital tier.
The authoritative annual data source for U.S. life settlement market analysis is Conning, an investment management firm founded in 1912 specializing in insurance industry research. Conning's annual life settlement strategic study, now in its 20th edition as "2025 Life Settlements – A Pause for Now" released November 2025, provides comprehensive analysis of U.S. transaction volumes, supply-demand mechanics, growth drivers, and 10-year forecasts. The study estimates average annual gross market potential at $224 billion, average annual transacted volume forecast at $4.6 billion across 2025–2034, and observes a measurable 2024 slowdown in new policy settlements against persistent long-term growth drivers including demographic momentum, alternative asset demand, and regulatory stability.
The European Life Settlement Association (ELSA) publishes a complementary factsheet on secondary market size tracking U.S. and global market dynamics with cross-validation of Conning data. The Life Insurance Settlement Association (LISA) publishes industry data and consumer education materials covering both seller-side and investor-side market dynamics. Industry data on policy lapse rates is published in the American Council of Life Insurers (ACLI) annual fact book, providing supporting context for the supply gap analysis (annual lapse rates of in-force U.S. life insurance face value substantially exceed annual life settlement transaction volumes, confirming the structural inefficiency identified in Conning's penetration rate framework).
U.S. demographic data supporting demographic growth driver analysis is published by the U.S. Census Bureau, projecting the 65+ population growing from approximately 58 million in 2026 to over 80 million by 2040. Federal investor accreditation under SEC Rule 501 of Regulation D applies to all life settlement direct-ownership investments. Historical market data including the 2007 pre-Global Financial Crisis peak of $12.2 billion (inflated by premium finance origination) and the 2011 post-crisis trough of $1.3 billion reflects publicly-documented industry transaction records. Conning's authoritative status reflects its 20-year continuous coverage of the asset class with institutional research methodology.
Invest in life settlement policies with institutional market access
HYV operates inside the $4.6 billion annual U.S. life settlement market with national sourcing reach and institutional diligence on every opportunity presented to accredited investors and their advisors.
Frequently asked questions
How large is the U.S. life settlement market in 2026?
The U.S. life settlement market transacts approximately $4.5–$5 billion in face value annually as of 2026. Conning's 20th annual strategic study, "2025 Life Settlements – A Pause for Now," released November 2025, projects average annual transaction volume of $4.6 billion across the 2025–2034 forecast period. The market has stabilized in this range over the past several years, recovering from post-Global Financial Crisis lows of $1.3 billion in 2011 and tripling in size over the past decade. The 2024 transaction volume showed a measurable slowdown — the source of the "Pause for Now" framing — but Conning attributes the pause to cyclical economic factors against persistent long-term growth drivers.
What is the addressable supply for life settlements?
Conning estimates the average annual gross market potential for U.S. life settlements at $224 billion — representing the face value of policies held by U.S. seniors aged 65+ that meet the structural eligibility criteria (sufficient face value, in-force status, post-contestability period, suitable policy type). Against this $224 billion addressable supply, the market transacts approximately $4.6 billion annually — a penetration rate of roughly 2.25%. The remaining 97%+ of eligible policies lapse, surrender, or remain in force without optimization. The structural inefficiency exists because lapse and surrender values are typically 4–7× lower than secondary market valuations, but most policyholders are unaware the secondary market option exists.
Why is the penetration rate only 2.25%?
The 2.25% penetration rate (annual transactions as a fraction of addressable supply) reflects four sequential bottlenecks: awareness, engagement, qualification, and transaction completion. Most eligible policyholders are not aware life settlements exist as an alternative to lapse or surrender — industry estimates suggest only 25–30% policyholder awareness in the eligible age band. Of those aware, only a fraction (estimated 15–20%) actively pursue offers. Of those who engage, transaction friction (regulatory waiting periods, underwriting timelines, broker capacity, suitability verification) constrains how many close per year. The bottleneck is not investor capital, which has consistently exceeded supply; it is originator capacity and consumer awareness on the supply side.
What did the Conning 2025 study find?
Conning's 2025 strategic study, titled "Life Settlements: A Pause for Now," released November 2025 as the firm's 20th annual life settlement market review, documents a measurable slowdown in new policy settlements during 2024 while maintaining a long-term growth outlook. Key findings: average annual gross market potential of $224 billion across the addressable supply pool; average annual transaction volume forecast of $4.6 billion across 2025–2034; persistent demographic growth drivers; continued institutional capital interest in alternative assets with low correlation to traditional markets; and a temporary slowdown attributable to cyclical economic factors. Lead author Scott Hawkins, Managing Director and Head of Insurance Research at Conning, frames the 2024 pause as cyclical against intact long-term structural drivers.
Why did the 2024 market pause occur?
Conning attributes the 2024 slowdown to a combination of cyclical economic factors: continued consumer uncertainty affecting policyholder decision-making timing, rising interest rates initially attracting some alternative allocation capital back into fixed income, and equity market volatility absorbing institutional alternative budgets in the short term. Importantly, the study frames these as cyclical headwinds against structural tailwinds — the demographic supply pipeline continues to grow (10,000 Americans turning 65 daily), institutional alternative demand remains positive, and regulatory infrastructure is mature. The 10-year forecast of $4.6 billion average annual volume reflects mean reversion expectations to the secular growth trajectory rather than projection of continued slowdown.
How does life settlement market size compare to other alternative assets?
The U.S. life settlement market at $4.6 billion annual transaction volume is small relative to traditional alternative asset categories — private equity transacts $500B+ annually, private credit several hundred billion, hedge fund AUM is measured in trillions. However, the more meaningful comparison is the structural supply-demand balance. Most large alternative categories have surplus institutional capital seeking deals. Life settlements have the opposite: surplus addressable supply seeking institutional capital. This structural imbalance is precisely what supports pricing discipline for buy-side investors and explains why institutional allocators (Apollo, Berkshire Hathaway, Partner Re, major family offices) maintain consistent allocations — the asset class offers genuine return premium for disciplined capital deployment.
Will the life settlement market continue growing through 2030?
Conning's 10-year forecast through 2034 projects continued growth in average annual transaction volume to approximately $4.6 billion, supported by four primary drivers: demographic momentum (the 65+ U.S. population growing from ~58M in 2026 to 80M+ by 2040), interest rate environment supporting alternative income demand, gradual policyholder awareness expansion through industry education, and regulatory stability across 43 states with comprehensive frameworks. The forecast is not without risk — economic conditions, regulatory shifts, or major awareness campaigns could move volumes meaningfully in either direction — but the structural drivers favor continued steady growth rather than dramatic expansion or contraction. The penetration rate is unlikely to move dramatically without major structural change in consumer awareness or distribution channels.
How does HYV access this market for accredited investors?
High Yield Vault operates inside the $4.6 billion annual U.S. secondary market with national sourcing reach through licensed provider channels and broker relationships across the regulated states. Every opportunity presented to accredited investors undergoes full institutional diligence — independent LE underwriting from recognized firms (21st Services, ISC, Fasano, Predictive Resources), AM Best A-rated carrier verification, regulatory compliance confirmation (state-of-insured framework), and the five-tier servicer infrastructure (custodian, master servicer, tracking agent, backup servicer, carrier). The deep market supply allows HYV to consistently present opportunities meeting institutional standards across multiple LE bands, carriers, and impairment categories — supporting the diversified portfolio construction framework appropriate to each investor's capital tier.
